
TORSELLO ANTONIO BIAGIO
- U08, Piano: 2, Stanza: 2011
Pubblicazioni
Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186(May 2025) [10.1016/j.biopha.2025.118044]. Dettaglio
Mingardi, J., Meanti, R., Paoli, C., Cifani, C., Torsello, A., Popoli, M., et al. (2025). Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What
Are the Connections?. CURRENT NEUROPHARMACOLOGY, 23(2), 172-186 [10.2174/1570159x22999240722095039]. DettaglioCostanzi, E., Grisetti, M., Bettucci, M., Meanti, R., Lonati, E., Morello, G., et al. (2025). Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy. Intervento presentato a: ISEV2025 Annual Meeting, Vienna. Dettaglio
Stea, E., Pugliano, M., Gualtierotti, R., Mazzucato, M., Santangelo, L., Annicchiarico, G., et al. (2025). Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): recommendations from Italian scientific societies, patient associations and regulators. PHARMACOLOGICAL RESEARCH, 216(June 2025) [10.1016/j.phrs.2025.107714]. Dettaglio
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Dettaglio